Zobrazeno 1 - 10
of 5 134
pro vyhledávání: '"Carcereny, E"'
Autor:
Carcereny E; Institut Català D'oncologia Badalona- Hospital Germans Trias I Pujol, B-Argo Group, Badalona, Spain. ecarcereny@iconcologia.net., Rodriguez-Abreu D; Hospital Universitario Insular de Gran Canaria, Las Palmas de Gran Canaria, Spain., Lopez R; Hospital Clínico Universitario de Valladolid, Valladolid, Spain., Franco F; Hospital Universitario Puerta de Hierro-Majadahonda, Madrid, Spain., Guirado M; Hospital General Universitario de Elche, Elche, Spain., Massutí B; Hospital General Universitario Dr. Balmis de Alicante, Alicante, Spain., Cobo M; Hospital Regional Universitario de Málaga, Málaga, Spain., Blasco A; Hospital General Universitario de Valencia, Valencia, Spain., Suay G; Hospital Universitari I Politècnic La Fe, Valencia, Spain., Del Barco E; Hospital Universitario de Salamanca, Salamanca, Spain., Ortega AL; Hospital Universitario de Jaén, Jaen, Spain., Sala MA; OSI Bilbao Basurto, Bilbao, Spain., Cordeiro P; Complejo Hospitalario Universitario A Coruña, A Coruña, Spain., Bernabé R; Hospital Universitario Virgen del Rocío, Seville, Spain., González Larriba JL; Hospital Universitario Clínico San Carlos, Madrid, Spain., Bosch-Barrera J; Josep Trueta and Precision Oncology Group (OncoGIR-Pro), Institut d'Investigacions Biomèdiques de Girona (IDIBGI), Catalan Institute of Oncology, Hospital Universitari Dr, Girona, Spain., Calzas J; Hospital Universitario de Fuenlabrada, Fuenlabrada, Madrid, Spain., Casal J; Complejo Hospitalario Universitario de Vigo, Vigo, Spain., Padilla A; Hospital Universitario, Nuestra Señora De La Candelaria, Santa Cruz de Tenerife, Spain., Sánchez-Hernandez A; Hospital Provincial de Castellón, Castellón, Spain., Provencio M; Hospital Universitario Puerta de Hierro-Majadahonda, Madrid, Spain.
Publikováno v:
Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico [Clin Transl Oncol] 2024 Jun 11. Date of Electronic Publication: 2024 Jun 11.
Autor:
Dafni, U., Soo, R.A., Peters, S., Tsourti, Z., Zygoura, P., Vervita, K., Han, J.-Y., De Castro, J., Coate, L., Früh, M., Hashemi, S.M.S., Nadal, E., Carcereny, E., Sala, M.A., Bernabé, R., Provencio, M., Cuffe, S., Roschitzki-Voser, H., Ruepp, B., Rosell, R., Stahel, R.A.
Publikováno v:
In ESMO Open June 2022 7(3)
Autor:
Centeno, C., Serra Mitja, P., Avila, M., Carcereny, E., Muñoz-Mármol, A.M., Moran, T., Castellà, E., Sanz-Santos, J., García Olivé, I., Ramirez Serrano, J.L., Rosell Gratacos, A., Andreo García, F.
Publikováno v:
In Pulmonology January-February 2022 28(1):28-33
Autor:
Soo RA; National University Cancer Institute, Singapore, Singapore., Dafni U; National and Kapodistrian University of Athens, Athens, ATTIKI, Greece., Han JY; National Cancer Center, Goyang, Gyeonggi, Korea (South), Republic of., Cho BC; Yonsei University College of Medicine, Seoul, Korea (South), Republic of., Nadal E; Institut Català d'Oncologia, Hospitalet de Llobregat, Barcelona, Spain., Yeo CM; Tan Tock Seng Hospital, Singapore, Singapore., Carcereny E; institute of Catalan Oncology Badalona, Badalona, Spain., de Castro J; Hospital Universitario La Paz, Madrid, Spain., Sala MA; Hospital de Basurto, Bilbao, Spain., Coate L; University Hospital Limerick, Limerick, Ireland., Provencio M; Hospital Universitario Puerta de Hierro Majadahonda, Majadahonda, Madrid, Spain., Britschgi C; University Hospital of Zurich and University of Zurich, Zurich, ZH, Switzerland., Vagenknecht P; ETOP IBCSG Partners Foundation, Bern, Switzerland., Dimopoulou G; Frontier Science Foundation-Hellas, Athens, Greece., Kammler R; International Breast Cancer Study Group, a division of ETOP IBCSG Partners Foundation, Bern, Switzerland., Finn SP; Trinity College Dublin, Dublin, Ireland., Peters S; Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne University, Lausanne, vaud, Switzerland., Stahel RA; University Hospital Zürich, Zurich, Switzerland.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2024 Sep 09. Date of Electronic Publication: 2024 Sep 09.
Autor:
Forster M; UCL Cancer Institute/University College London Hospitals NHS Foundation, London, United Kingdom., Brana I; Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology, Barcelona, Spain.; Department of Medical Oncology, Vall d'Hebron University Hospital, Barcelona, Spain., Pousa AL; Hospital de la Santa Creu i Sant Pau, Barcelona, Spain., Doger B; Fundación Jiménez Diaz, Madrid, Spain., Roxburgh P; Wolfson Wohl Cancer Research Centre, Institute of Cancer Sciences, University of Glasgow and Beatson West of Scotland Cancer Centre, Scotland, United Kingdom., Bajaj P; Tasman Oncology, Southport, Australia., Peguero J; Oncology Consultants, Houston, Pennsylvania., Krebs M; Division of Cancer Sciences, The University of Manchester and The Christie NHS Foundation Trust, Manchester, United Kingdom., Carcereny E; Catalan Institute of Oncology Badalona-Hospital Germans Trias i Pujol, B-ARGO Group, Badalona, Spain., Patel G; Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom., Mueller C; Clinical Development, Immutep GmbH, Berlin, Germany., Brignone C; Research & Development, Immutep S.A.S., Saint-Aubin, France., Triebel F; Research & Development, Immutep S.A.S., Saint-Aubin, France.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2024 Sep 03; Vol. 30 (17), pp. 3726-3734.
Autor:
Hochmair MJ; Department of Respiratory and Critical Care Medicine, Karl Landsteiner Institute of Lung Research and Pulmonary Oncology, Klinik Floridsdorf, Vienna, Austria. Electronic address: maximilian.hochmair@gesundheitsverbund.at., Vermaelen K; Department of Pulmonary Medicine, Ghent University Hospital, Ghent, Oost-Vlaanderen, Belgium., Mountzios G; Department of Medical Oncology and Clinical Trials Unit, Henry Dunant Hospital Center, Athens, Greece., Carcereny E; Medical Oncology Department, Catalan Institute of Oncology Badalona, Badalona Applied Research Group in Oncology, Badalona, Barcelona, Spain., Dooms C; Department of Respiratory Diseases, University Hospitals KU Leuven, Leuven, Belgium., Lee SH; Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea., Morocz E; Pulmonology Hospital, Törökbálint, Hungary., Kato T; Department of Thoracic Oncology, Kanagawa Cancer Center, Yokohama, Japan., Ciuleanu TE; Institutul Oncologic Prof Dr Ion Chiricuta and University of Medicine and Pharmacy Iuliu Hatieganu, Cluj-Napoca, Romania., Dy GK; Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA., Parente B; Pulmonology Department, Hospital CUF Porto, Porto, Portugal., O'Byrne KJ; Princess Alexandra Hospital, Translational Research Institute and Queensland University of Technology, Brisbane, Queensland, Australia., Chu QS; Division of Medical Oncology, Department of Oncology, Cross Cancer Institute, University of Alberta, Edmonton, Alberta, Canada., Castro Junior G; Hospital Sírio Libanês, São Paulo, Brazil., Girard N; Institut du Thorax Curie Montsouris, Institut Curie, Paris, France; UVSQ, Paris Saclay, Versailles, France., Snyder W; Amgen Inc., Thousand Oaks, CA, USA., Tran Q; Amgen Inc., Thousand Oaks, CA, USA., Kormany W; Amgen Inc., Thousand Oaks, CA, USA., Houk B; Amgen Inc., Thousand Oaks, CA, USA., Mehta B; Amgen Inc., Thousand Oaks, CA, USA., Curioni-Fontecedro A; Department of Medical Oncology and Hematology, University Hospital Zurich, Zurich, Switzerland; University of Fribourg and Hospital of Fribourg, Fribourg, Switzerland.
Publikováno v:
European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2024 Sep; Vol. 208, pp. 114204. Date of Electronic Publication: 2024 Jul 05.
Autor:
Calvo V; Medical Oncology Department, Hospital Universitario Puerta de Hierro Majadahonda, Madrid, Spain. Electronic address: vircalvo@hotmail.com., Niazmand E; TIB Leibniz Information Centre for Science and Technology, Hannover, Germany; L3S Research, Hannover, Germany., Carcereny E; Medical Oncology Department, Catalan Institute of Oncology (ICO)-Badalona Badalona-Applied Research Group in Oncology (B-ARGO), Barcelona, Spain., Rodriguez-Abreu D; Medical Oncology Department, Hospital Insular de Gran Canaria, Las Palmas de Gran Canaria, Spain., Cobo M; BIONAND, Unidad de Gestión Clínica Intercentros de Oncología Médica, Hospitales Universitarios Regional y Virgen de la Victoria, IBIMA, Málaga. Spain., López-Castro R; Medical Oncology Department, Hospital Clínico Universitario de Valladolid, Valladolid, Spain., Guirado M; Medical Oncology Department, Hospital General Universitario de Elche, Elche, Spain., Camps C; Medical Oncology Departametnt, Hospital General Universitario de Valencia, Valencia, Spain., Laura Ortega A; Medical Oncology Department, Hospital Universitario de Jaen, Jaen, Spain., Bernabé R; Medical Oncology Department, Hospital Universitario Virgen del Rocío, Sevilla, Spain., Massutí B; Medical Oncology Department, Hospital General Universitario Doctor Balmis, Alicante, Spain., Garcia-Campelo R; Medical Oncology Department, Hospital Universitario A Coruña, A Coruña, Spain., Del Barco E; Medical Oncology Department, Hospital Universitario de Salamanca-IBSAL, Salamanca, Spain., Luis González-Larriba J; Medical Oncology Department, Hospital Clínico San Carlos, Madrid, Spain., Bosch-Barrera J; Medical Oncology Department, Catalan Institute of Oncology, University Hospital Dr. Josep Trueta, Precision Oncology Group (OncoGIR-Pro), Girona BiomedicaI Research Institute (IDIBGI-CERCA), Girona, Spain., Martínez M; Medical Oncology Department, Hospital Universitario Puerta de Hierro Majadahonda, Madrid, Spain., Torrente M; Medical Oncology Department, Hospital Universitario Puerta de Hierro Majadahonda, Madrid, Spain., Vidal ME; TIB Leibniz Information Centre for Science and Technology, Hannover, Germany; L3S Research, Hannover, Germany., Provencio M; Medical Oncology Department, Hospital Universitario Puerta de Hierro Majadahonda, Madrid, Spain. Electronic address: mprovenciop@gmail.com.
Publikováno v:
Lung cancer (Amsterdam, Netherlands) [Lung Cancer] 2024 Sep; Vol. 195, pp. 107920. Date of Electronic Publication: 2024 Aug 09.
Autor:
Candal-Pedreira C; Area of Preventive Medicine and Public Health, University of Santiago de Compostela, Spain; Spanish Lung Cancer Group, Spain., Ruano-Ravina A; Area of Preventive Medicine and Public Health, University of Santiago de Compostela, Spain; Spanish Lung Cancer Group, Spain. Electronic address: alberto.ruano@usc.es., Calvo de Juan V; Spanish Lung Cancer Group, Spain; Hospital Universitario Puerta de Hierro-Majadahonda, Madrid, Spain., Cobo M; Spanish Lung Cancer Group, Spain; Medical Oncology Intercenter Unit, Regional and Virgen de la Victoria University Hospitals, IBIMA, Málaga, Spain., Cantero A; Spanish Lung Cancer Group, Spain; Medical Oncology Intercenter Unit, Regional and Virgen de la Victoria University Hospitals, IBIMA, Málaga, Spain., Rodríguez-Abreu D; Spanish Lung Cancer Group, Spain; Hospital Universitario Insular de Gran Canaria, Las Palmas de Gran Canaria, Spain., Estival A; Spanish Lung Cancer Group, Spain; Hospital Universitario Insular de Gran Canaria, Las Palmas de Gran Canaria, Spain., Carcereny E; Spanish Lung Cancer Group, Spain; Institut Català D'Oncologia Badalona - Hospital Germans Trias i Pujol, B-ARGO, IGTP, Badalona, Spain., Hernandez A; Spanish Lung Cancer Group, Spain; Institut Català D'Oncologia Badalona - Hospital Germans Trias i Pujol, B-ARGO, IGTP, Badalona, Spain., López Castro R; Spanish Lung Cancer Group, Spain; Hospital Clínico Universitario de Valladolid, Valladolid, Spain., Medina A; Spanish Lung Cancer Group, Spain; Hospital Clínico Universitario de Valladolid, Valladolid, Spain., García Campelo R; Spanish Lung Cancer Group, Spain; Complejo Hospitalario Universitario A Coruña, A Coruña, Spain., Fernández Bruno M; Spanish Lung Cancer Group, Spain; Complejo Hospitalario Universitario A Coruña, A Coruña, Spain., Barnabé R; Spanish Lung Cancer Group, Spain; Hospital Universitario Virgen del Rocio, Sevilla, Spain., Bosch-Barrera J; Spanish Lung Cancer Group, Spain; Catalan Institute of Oncology, Hospital Universitari Dr. Josep Trueta and Precision Oncology Group (OncoGIR-Pro), Institut d'Investigacions Biomèdiques de Girona (IDIBGI), Girona, Spain., Massutí B; Spanish Lung Cancer Group, Spain; Hospital General Universitario Dr. Balmis de Alicante, Alicante, Spain., Dómine M; Spanish Lung Cancer Group, Spain; Hospital Universitario Fundación Jiménez Díaz. IIS-FJD, Madrid, Spain., Camps C; Spanish Lung Cancer Group, Spain; Hospital General Universitario de Valencia, Valencia, Spain., Ortega AL; Spanish Lung Cancer Group, Spain; Hospital Universitario de Jaén, Jaén, Spain., Provencio M; Spanish Lung Cancer Group, Spain.
Publikováno v:
Archivos de bronconeumologia [Arch Bronconeumol] 2024 Jul 15. Date of Electronic Publication: 2024 Jul 15.
Autor:
Peressini M; Tumor Microenvironment and Immunotherapy Research Group, Instituto de Investigación Hospital 12 de Octubre (i+12), Madrid, Spain., Garcia-Campelo R; Department of Medical Oncology, Hospital Universitario de A Coruña, A Coruña, Spain., Massuti B; Department of Medical Oncology, Hospital General Universitario de Alicante, Alicante, Spain., Martí C; Department of Medical Oncology, Hospital Universitario Sant Joan de Reus, Tarragona, Spain., Cobo M; Department of Medical Oncology, UGC intercentros de Oncología Médica, Hospitales Universitarios Regional y Virgen de la Victoria, IBIMA, Málaga, Spain., Gutiérrez V; Department of Medical Oncology, Complejo Hospitalario Regional de Málaga, Málaga, Spain., Dómine M; Department of Medical Oncology, Hospital Universitario Fundación Jimenez Díaz, Madrid, Spain., Fuentes J; Department of Medical Oncology, Hospital Universitario Virgen de Valme, Sevilla, Spain., Majem M; Department of Medical Oncology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain., de Castro J; Department of Medical Oncology, Hospital Universitario La Paz, IdiPAZ, Madrid, Spain., Córdoba JF; Department of Medical Oncology, Hospital Universitario Arnau de Villanova, Lérida, Spain., Diz MP; Department of Medical Oncology, Complejo Asistencial Universitario de León, León, Spain., Isla D; Department of Medical Oncology, Hospital Universitario Lozano Blesa, Zaragoza, Spain., Esteban E; Department of Medical Oncology, Hospital Universitario Central de Asturias, Asturias, Spain., Carcereny E; Department of Medical Oncology, Instituto Catalán de Oncología de Badalona, Badalona-Applied Research Group in Oncology (B-ARGO), Barcelona, Spain., Vila L; Department of Medical Oncology, Parc Taulí Hospital Universitari, Institut d'Investigació i Innovació Parc Taulí (I3PT-CERCA), Universitat Autònoma de Barcelona, Barcelona, Spain., Moreno-Vega A; Department of Medical Oncology, Hospital Universitario Reina Sofia, Córdoba, Spain., Ros S; Department of Medical Oncology, Hospital Universitario Virgen de La Arrixaca, Murcia, Spain., Moreno A; Department of Medical Oncology, Hospital de Galdakao, Vizcaya, Spain., García FJ; Department of Medical Oncology, Hospital Universitario Son Llatzer, Mallorca, Spain., Huidobro G; Department of Medical Oncology, Hospital Universitario Álvaro Cunqueiro, Vigo, Spain., Aguado C; Department of Medical Oncology, Hospital Universitario Clínico San Carlos, Madrid, Spain., Cebey-López V; Department of Medical Oncology, Hospital Clínico Universitario de Santiago, Santiago de Compostela, Spain., Valdivia J; Department of Medical Oncology, Hospital Universitario Virgen de las Nieves, Granada, Spain., Palmero R; Department of Medical Oncology, Instituto Catalán de Oncología de Hospitalet de Llobregat, Barcelona, Spain., Lianes P; Department of Medical Oncology, Hospital de Mataró, Barcelona, Spain., López-Brea M; Department of Medical Oncology, Hospital Universitario Marqués de Valdecilla, Santander, Spain., Vidal OJ; Department of Medical Oncology, Hospital Universitario La Fe, Valencia, Spain., Provencio M; Department of Medical Oncology, Hospital Universitario Puerta de Hierro, Madrid, Spain., Arriola E; Department of Medical Oncology, Hospital del Mar, Barcelona, Spain.; CIBERONC, Instituto de Salud Carlos III, Madrid, Spain., Baena J; Tumor Microenvironment and Immunotherapy Research Group, Instituto de Investigación Hospital 12 de Octubre (i+12), Madrid, Spain.; Department of Medical Oncology, Hospital Universitario 12 de Octubre, Madrid, Spain.; Lung Cancer Clinical Research Group, Centro Nacional de Investigaciones Oncológicas (CNIO), Madrid, Spain., Herrera M; Tumor Microenvironment and Immunotherapy Research Group, Instituto de Investigación Hospital 12 de Octubre (i+12), Madrid, Spain.; Department of Medical Oncology, Hospital Universitario 12 de Octubre, Madrid, Spain.; Lung Cancer Clinical Research Group, Centro Nacional de Investigaciones Oncológicas (CNIO), Madrid, Spain., Bote H; Tumor Microenvironment and Immunotherapy Research Group, Instituto de Investigación Hospital 12 de Octubre (i+12), Madrid, Spain.; Department of Medical Oncology, Hospital Universitario 12 de Octubre, Madrid, Spain.; Lung Cancer Clinical Research Group, Centro Nacional de Investigaciones Oncológicas (CNIO), Madrid, Spain., Molero M; Tumor Microenvironment and Immunotherapy Research Group, Instituto de Investigación Hospital 12 de Octubre (i+12), Madrid, Spain.; Lung Cancer Clinical Research Group, Centro Nacional de Investigaciones Oncológicas (CNIO), Madrid, Spain., Adradas V; Tumor Microenvironment and Immunotherapy Research Group, Instituto de Investigación Hospital 12 de Octubre (i+12), Madrid, Spain.; Lung Cancer Clinical Research Group, Centro Nacional de Investigaciones Oncológicas (CNIO), Madrid, Spain., Ponce-Aix S; Department of Medical Oncology, Hospital Universitario 12 de Octubre, Madrid, Spain.; Lung Cancer Clinical Research Group, Centro Nacional de Investigaciones Oncológicas (CNIO), Madrid, Spain., Nuñez-Buiza A; Department of Medical Oncology, Hospital Universitario 12 de Octubre, Madrid, Spain.; Lung Cancer Clinical Research Group, Centro Nacional de Investigaciones Oncológicas (CNIO), Madrid, Spain., Ucero Á; CIBERONC, Instituto de Salud Carlos III, Madrid, Spain.; Department of Medical Oncology, Hospital Universitario 12 de Octubre, Madrid, Spain.; Lung Cancer Clinical Research Group, Centro Nacional de Investigaciones Oncológicas (CNIO), Madrid, Spain.; Department of Physiology, Complutense University, Madrid, Spain., Hernandez S; Department of Pathology, Hospital Universitario 12 de Octubre, Madrid, Spain., Lopez-Rios F; CIBERONC, Instituto de Salud Carlos III, Madrid, Spain.; Department of Pathology, Hospital Universitario 12 de Octubre, Madrid, Spain.; Department of Legal Medicine, Psychiatry and Pathology, Complutense University, Madrid, Spain., Conde E; CIBERONC, Instituto de Salud Carlos III, Madrid, Spain.; Department of Pathology, Hospital Universitario 12 de Octubre, Madrid, Spain.; Department of Legal Medicine, Psychiatry and Pathology, Complutense University, Madrid, Spain., Paz-Ares L; CIBERONC, Instituto de Salud Carlos III, Madrid, Spain.; Department of Medical Oncology, Hospital Universitario 12 de Octubre, Madrid, Spain.; Lung Cancer Clinical Research Group, Centro Nacional de Investigaciones Oncológicas (CNIO), Madrid, Spain.; Department of Physiology, Complutense University, Madrid, Spain.; Department of Medicine, Complutense University, Madrid, Spain., Zugazagoitia J; Tumor Microenvironment and Immunotherapy Research Group, Instituto de Investigación Hospital 12 de Octubre (i+12), Madrid, Spain.; CIBERONC, Instituto de Salud Carlos III, Madrid, Spain.; Department of Medical Oncology, Hospital Universitario 12 de Octubre, Madrid, Spain.; Lung Cancer Clinical Research Group, Centro Nacional de Investigaciones Oncológicas (CNIO), Madrid, Spain.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2024 Jul 15; Vol. 30 (14), pp. 3036-3049.
Autor:
Solomon BJ; Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia., Dagogo-Jack I; Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts., Lee SH; Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea., Boyer MJ; Chris O'Brien Lifehouse, Camperdown, New South Wales, Australia., Ramalingam SS; Winship Cancer Institute of Emory University, Atlanta, Georgia., Carcereny E; Institut Català d'Oncologia de Badalona, Servicio de Oncología Médica, Badalona, Spain., Felip E; Vall d'Hebron University Hospital and Vall d'Hebron Institute of Oncology, Centro Cellex, Barcelona, Spain., Han JY; National Cancer Center, Gyeonggi-do, South Korea., Hida T; Aichi Cancer Center Central Hospital, Nagoya, Japan., Hughes BGM; The Prince Charles Hospital, Cancer Care Services, Chermside, Queensland, Australia., Kim SW; Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea., Nishio M; The Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan., Seto T; National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan., Okamoto T; National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan., Zhang X; Pfizer, New York, New York., Martini JF; Pfizer, San Diego, California., Wang E; Pfizer, San Diego, California.; Present address: IDEAYA Biosciences, South San Francisco, California., De Beukelaer S; Pfizer, Zurich, Switzerland.; Present address: Monte Rosa Therapeutics, Basel, Switzerland., Bauer TM; Tennessee Oncology, Nashville, Tennessee.
Publikováno v:
JTO clinical and research reports [JTO Clin Res Rep] 2024 May 16; Vol. 5 (7), pp. 100685. Date of Electronic Publication: 2024 May 16 (Print Publication: 2024).